Evaluation of a Novel Method for the Assessment of Ocular Adverse Events and Associated Functional Impact in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Belantamab Mafodotin, Lenalidomide, and Dexamethasone in the Phase 1/2 Belard Trial

被引：0

作者：

Terpos, Evangelos ^{[1
]}

Ntanasis-Stathopoulos, Ioannis ^{[2
]}

Gavriatopoulou, Maria ^{[2
]}

Malandrakis, Panagiotis ^{[2
]}

Fotiou, Despina ^{[2
]}

Migkou, Magdalini ^{[2
]}

Theodorakakou, Foteini ^{[2
]}

Spiliopoulou, Vasiliki ^{[2
]}

Syrigou, Rodanthi ^{[2
]}

Eleutherakis-Papaiakovou, Evangelos ^{[2
]}

Douvali, Maria ^{[3
]}

Gkolfinopoulos, Stavros ^{[4
]}

Kastritis, Efstathios ^{[2
]}

Dimopoulos, Meletios A. ^{[2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Drosia, Greece

[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[3] Ophthalm Ctr, Aktina Ctr, Athens, Greece

[4] Hlth Data Specialists, Dublin, Ireland

来源：

关键词：

D O I：

10.1182/blood-2023-173074

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4